Prescribing data should be off-limits to drug reps
More than seven out of 10 people who responded to a Drug Topics Instant Poll in June are in favor of a New Hampshire law that would ban pharmacies and data-mining companies from selling their prescription data for commercial purposes. They feel the law has merit since it would stop drug reps from getting access to data on what drugs physicians prescribe and using the information to influence prescribing.
Prescribing data should be off-limits to drug reps
More than seven out of 10 people who responded to a Drug Topics Instant Poll in June are in favor of a New Hampshire law that would ban pharmacies and data-mining companies from selling their prescription data for commercial purposes. They feel the law has merit since it would stop drug reps from getting access to data on what drugs physicians prescribe and using the information to influence prescribing. Some 10% of respondents disagreed with the law, since they feel pharmacies should be able to sell this information. A smaller minority-7%-believe the law is not a good idea since without access to the data, manufacturers would not be able to alert physicians about problems related to specific products. Another 5% of respondents think the law will create a bureaucratic headache, since New Hampshire is the only state set to pass this legislation; other states don't have these compliance requirements. Finally 2% said they didn't know whether the law is a good idea or not. A total of 629 people voted in this poll.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
